Since the outbreak of the novel coronavirus disease (COVID-19), the therapeutic and management options to reduce the burden of the COVID-19 disease are under investigation. IVIG therapy is used as an effective treatment for immunodeficient patients and patients with inflammatory or autoimmune conditions. The therapeutic effect of IVIG in COVID-19 patients has been investigated. But, the results are controversial and some studies reported no benefit of IVIG therapy. More clinical trials on the effect of IVIG therapy in COVID-19 patients should be performed to establish a certain conclusion about IVIG effectiveness.
CITATION STYLE
Kolahchi, Z., Sohrabi, H., Ekrami Nasab, S., Jelodari Mamaghani, H., Keyfari Alamdari, M., & Rezaei, N. (2021, December 1). Potential therapeutic approach of intravenous immunoglobulin against COVID-19. Allergy, Asthma and Clinical Immunology. BioMed Central Ltd. https://doi.org/10.1186/s13223-021-00609-3
Mendeley helps you to discover research relevant for your work.